Artificial intelligence-enabled clinical decision support: device regulation and decision influence
Journal of the American Medical Informatics Association · 16.11.2026
DOI: 10.1093/jamia/ocag155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, online erschienen am 16.11.2026. Verfasst von Huzaifa S Wasanwala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, United States. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
Artificial intelligence (AI)-enabled clinical decision support (CDS) challenges core assumptions of the Food and Drug Administration’s (FDA) recently updated CDS guidance, including the concepts of independent clinician review of outputs and manufacturer-intended use for exempting certain CDS tools from medical device regulation. Materials and Methods We examine the FDA’s January 2026 CDS guidance in the context of the evolving landscape of AI-enabled CDS tools, clinician interaction studies with AI-enabled CDS, and AI governance frameworks.
Results
Although the FDA’s framework distinguishes non-device CDS from regulated software, AI-enabled CDS may synthesize and transform clinical information in ways that are difficult to verify during routine care, increasing clinician susceptibility to automation bias.
Discussion
Incorporating pragmatic triggers into existing governance frameworks can help identify scenarios with a heightened risk for clinical decision influence.
Conclusion
Oversight calibrated to real-world clinical decision influence is needed to strengthen practical safety standards for AI-enabled CDS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, United States.
- Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511, United States.
- Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.
- Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
ORCID-Profile: Jacob T Kannarkat
Zitieren
APA
Wasanwala, H. S., Kannarkat, J. T., & Bates, D. W. (2026). Artificial intelligence-enabled clinical decision support: device regulation and decision influence. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocag155
Vancouver
Wasanwala HS, Kannarkat JT, Bates DW. Artificial intelligence-enabled clinical decision support: device regulation and decision influence. Journal of the American Medical Informatics Association. 2026. doi:10.1093/jamia/ocag155
BibTeX
@article{Wasanwala2026,
author = {Wasanwala, Huzaifa S and Kannarkat, Jacob T and Bates, David W},
title = {Artificial intelligence-enabled clinical decision support: device regulation and decision influence},
journal = {Journal of the American Medical Informatics Association},
year = {2026},
doi = {10.1093/jamia/ocag155}
}
EUVIMED